
Stuart Snyder
Examiner (ID: 19177)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648 |
| Total Applications | 524 |
| Issued Applications | 295 |
| Pending Applications | 33 |
| Abandoned Applications | 200 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5219671
[patent_doc_number] => 20070160982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'DEVELOPMENT OF INFLUENZA A ANTIVIRALS'
[patent_app_type] => utility
[patent_app_number] => 11/566214
[patent_app_country] => US
[patent_app_date] => 2006-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13108
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160982.pdf
[firstpage_image] =>[orig_patent_app_number] => 11566214
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/566214 | Development of influenza A antivirals | Dec 1, 2006 | Issued |
Array
(
[id] => 5315874
[patent_doc_number] => 20090280472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'Method for Detection of Antigens'
[patent_app_type] => utility
[patent_app_number] => 11/910598
[patent_app_country] => US
[patent_app_date] => 2006-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5587
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280472.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910598
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910598 | Method for Detection of Antigens | Nov 29, 2006 | Abandoned |
Array
(
[id] => 5079191
[patent_doc_number] => 20070122415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-31
[patent_title] => 'Compound and method for suppressing retroviral replication'
[patent_app_type] => utility
[patent_app_number] => 11/607256
[patent_app_country] => US
[patent_app_date] => 2006-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17134
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20070122415.pdf
[firstpage_image] =>[orig_patent_app_number] => 11607256
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/607256 | Compound and method for suppressing retroviral replication | Nov 28, 2006 | Abandoned |
Array
(
[id] => 5367668
[patent_doc_number] => 20090305227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'HIV-1 LATENCY MODEL FOR HIGH THROUGHPUT SCREENING'
[patent_app_type] => utility
[patent_app_number] => 12/096245
[patent_app_country] => US
[patent_app_date] => 2006-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9928
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305227.pdf
[firstpage_image] =>[orig_patent_app_number] => 12096245
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/096245 | HIV-1 latency model for high throughput screening | Nov 26, 2006 | Issued |
Array
(
[id] => 32853
[patent_doc_number] => 07785773
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-08-31
[patent_title] => 'Method of diagnosis and kit therefor'
[patent_app_type] => utility
[patent_app_number] => 11/604169
[patent_app_country] => US
[patent_app_date] => 2006-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11455
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/785/07785773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11604169
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/604169 | Method of diagnosis and kit therefor | Nov 21, 2006 | Issued |
| 10/569797 | Induction of antiviral neutralizing antibodies in humans and animals | Nov 19, 2006 | Abandoned |
Array
(
[id] => 10176200
[patent_doc_number] => 09206396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Methods and devices for quantitative viral assays'
[patent_app_type] => utility
[patent_app_number] => 11/560714
[patent_app_country] => US
[patent_app_date] => 2006-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 9661
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11560714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/560714 | Methods and devices for quantitative viral assays | Nov 15, 2006 | Issued |
Array
(
[id] => 5538736
[patent_doc_number] => 20090220541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/092131
[patent_app_country] => US
[patent_app_date] => 2006-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15048
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220541.pdf
[firstpage_image] =>[orig_patent_app_number] => 12092131
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/092131 | EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES | Nov 5, 2006 | Abandoned |
Array
(
[id] => 5521460
[patent_doc_number] => 20090029441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-29
[patent_title] => 'BIONANOMATERIALS AND THEIR SYNTHESIS'
[patent_app_type] => utility
[patent_app_number] => 12/090579
[patent_app_country] => US
[patent_app_date] => 2006-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11273
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20090029441.pdf
[firstpage_image] =>[orig_patent_app_number] => 12090579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/090579 | Bionanomaterials and their synthesis | Oct 31, 2006 | Issued |
Array
(
[id] => 224752
[patent_doc_number] => 07604935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'Soluble rubella E1 envelope protein variants'
[patent_app_type] => utility
[patent_app_number] => 11/584887
[patent_app_country] => US
[patent_app_date] => 2006-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 15687
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/604/07604935.pdf
[firstpage_image] =>[orig_patent_app_number] => 11584887
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/584887 | Soluble rubella E1 envelope protein variants | Oct 22, 2006 | Issued |
Array
(
[id] => 6254266
[patent_doc_number] => 20100028855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'DETECTION OF INFLUENZA VIRUS TYPE B'
[patent_app_type] => utility
[patent_app_number] => 12/298133
[patent_app_country] => US
[patent_app_date] => 2006-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6623
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20100028855.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298133
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298133 | DETECTION OF INFLUENZA VIRUS TYPE B | Oct 20, 2006 | Abandoned |
Array
(
[id] => 5210367
[patent_doc_number] => 20070248951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'DETERMINATION METHOD AND DETERMINATION KIT'
[patent_app_type] => utility
[patent_app_number] => 11/550913
[patent_app_country] => US
[patent_app_date] => 2006-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7070
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20070248951.pdf
[firstpage_image] =>[orig_patent_app_number] => 11550913
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/550913 | DETERMINATION METHOD AND DETERMINATION KIT | Oct 18, 2006 | Abandoned |
Array
(
[id] => 5051337
[patent_doc_number] => 20070031882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules'
[patent_app_type] => utility
[patent_app_number] => 11/545891
[patent_app_country] => US
[patent_app_date] => 2006-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48451
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20070031882.pdf
[firstpage_image] =>[orig_patent_app_number] => 11545891
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/545891 | Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules | Oct 10, 2006 | Abandoned |
Array
(
[id] => 314656
[patent_doc_number] => 07524626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Rapid production of high titer virus'
[patent_app_type] => utility
[patent_app_number] => 11/542093
[patent_app_country] => US
[patent_app_date] => 2006-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10329
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524626.pdf
[firstpage_image] =>[orig_patent_app_number] => 11542093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/542093 | Rapid production of high titer virus | Oct 2, 2006 | Issued |
Array
(
[id] => 865131
[patent_doc_number] => 07368543
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-06
[patent_title] => 'Diagnosis and treatment of hepatic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/537582
[patent_app_country] => US
[patent_app_date] => 2006-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 11896
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/368/07368543.pdf
[firstpage_image] =>[orig_patent_app_number] => 11537582
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/537582 | Diagnosis and treatment of hepatic disorders | Sep 28, 2006 | Issued |
Array
(
[id] => 5642303
[patent_doc_number] => 20060280758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Modified vaccinia ankara virus variant'
[patent_app_type] => utility
[patent_app_number] => 11/508797
[patent_app_country] => US
[patent_app_date] => 2006-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10918
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20060280758.pdf
[firstpage_image] =>[orig_patent_app_number] => 11508797
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/508797 | Modified Vaccinia Ankara virus variant | Aug 22, 2006 | Issued |
Array
(
[id] => 263582
[patent_doc_number] => 07569340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/506200
[patent_app_country] => US
[patent_app_date] => 2006-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7480
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569340.pdf
[firstpage_image] =>[orig_patent_app_number] => 11506200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/506200 | Nanoarrays of single virus particles, methods and instrumentation for the fabrication and use thereof | Aug 17, 2006 | Issued |
Array
(
[id] => 563724
[patent_doc_number] => 07465538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-16
[patent_title] => 'Multiplex flow assays preferably with magnetic particles as solid phase'
[patent_app_type] => utility
[patent_app_number] => 11/502117
[patent_app_country] => US
[patent_app_date] => 2006-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9484
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/465/07465538.pdf
[firstpage_image] =>[orig_patent_app_number] => 11502117
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/502117 | Multiplex flow assays preferably with magnetic particles as solid phase | Aug 8, 2006 | Issued |
Array
(
[id] => 4739908
[patent_doc_number] => 20080233561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Method for Measuring Cytopathic Effect Due to Viral Infection in Cells Using Electric Cell-Substrate Impedance Sensing'
[patent_app_type] => utility
[patent_app_number] => 11/996892
[patent_app_country] => US
[patent_app_date] => 2006-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8363
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233561.pdf
[firstpage_image] =>[orig_patent_app_number] => 11996892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/996892 | Method for Measuring Cytopathic Effect Due to Viral Infection in Cells Using Electric Cell-Substrate Impedance Sensing | Jul 18, 2006 | Abandoned |
Array
(
[id] => 448280
[patent_doc_number] => 07250264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-31
[patent_title] => 'Diagnosis and treatment of hepatic disorders'
[patent_app_type] => utility
[patent_app_number] => 11/457740
[patent_app_country] => US
[patent_app_date] => 2006-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 7
[patent_no_of_words] => 11856
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250264.pdf
[firstpage_image] =>[orig_patent_app_number] => 11457740
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/457740 | Diagnosis and treatment of hepatic disorders | Jul 13, 2006 | Issued |